TRIB2 and osteosarcoma: Further to this, using RNA sequencing-based transcriptional profiling of isogenic osteosarcoma U2OS cells with different TRIB2 status, a recent study identified several small-molecule compounds, including harmine and piperlongumine, that reverse TRIB2-dependent transcriptional signatures [71].